Future Growth of the Meningococcal Vaccine Market
The meningococcal vaccine market is poised for substantial growth from 2024 to 2034. With an initial valuation of USD 3,950.2 million in 2024, the market is projected to achieve an impressive USD 9,014 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.6%.
https://www.globenewswire.com/news-release/2024/12/19/2999459/0/en/Meningococcal-Vaccine-Market-is-Set-to-Grow-from-USD-3-950-2-Million-in-2024-to-USD-9-014-Million-by-2034-Registering-a-Robust-CAGR-of-8-6-FMI.html
The meningococcal vaccine market is poised for substantial growth from 2024 to 2034. With an initial valuation of USD 3,950.2 million in 2024, the market is projected to achieve an impressive USD 9,014 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.6%.
https://www.globenewswire.com/news-release/2024/12/19/2999459/0/en/Meningococcal-Vaccine-Market-is-Set-to-Grow-from-USD-3-950-2-Million-in-2024-to-USD-9-014-Million-by-2034-Registering-a-Robust-CAGR-of-8-6-FMI.html
Future Growth of the Meningococcal Vaccine Market
The meningococcal vaccine market is poised for substantial growth from 2024 to 2034. With an initial valuation of USD 3,950.2 million in 2024, the market is projected to achieve an impressive USD 9,014 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.6%.
https://www.globenewswire.com/news-release/2024/12/19/2999459/0/en/Meningococcal-Vaccine-Market-is-Set-to-Grow-from-USD-3-950-2-Million-in-2024-to-USD-9-014-Million-by-2034-Registering-a-Robust-CAGR-of-8-6-FMI.html
0 Comments
·0 Shares
·18 Views
·0 Reviews
